Re: Abiraterone and Increased Survival in Metastatic Prostate Cancer

被引：0
|
作者：
Richie, Jerome P. [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Cambridge, MA 02138 USA
来源：
EUROPEAN UROLOGY | 2011年 / 60卷 / 04期
关键词：
D O I：
10.1016/j.eururo.2011.07.033
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：871 / 871
页数：1
相关论文
共 50 条
  • [1] Re: Abiraterone and Increased Survival in Metastatic Prostate Cancer
    Cheetham, Philippa J.
    Petrylak, Daniel P.
    [J]. EUROPEAN UROLOGY, 2012, 61 (04) : 850 - 850
  • [2] Re: Abiraterone and Increased Survival in Metastatic Prostate Cancer Editorial Comment
    Walsh, Patrick C.
    [J]. JOURNAL OF UROLOGY, 2011, 186 (06): : 2253 - 2254
  • [3] Abiraterone and Increased Survival in Metastatic Prostate Cancer
    Sonpavde, Guru
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (08): : 766 - 767
  • [4] Abiraterone and Increased Survival in Metastatic Prostate Cancer
    De Bono, Johann S.
    Logothetis, Christopher J.
    Molina, Arturo
    Fizazi, Karim
    North, Scott
    Chu, Luis
    Chi, Kim N.
    Jones, Robert J.
    Goodman, Oscar B., Jr.
    Saad, Fred
    Staffurth, John N.
    Mainwaring, Paul
    Harland, Stephen
    Flaig, Thomas W.
    Hutson, Thomas E.
    Cheng, Tina
    Patterson, Helen
    Hainsworth, John D.
    Ryan, Charles J.
    Sternberg, Cora N.
    Ellard, Susan L.
    Flechon, Aude
    Saleh, Mansoor
    Scholz, Mark
    Efstathiou, Eleni
    Zivi, Andrea
    Bianchini, Diletta
    Loriot, Yohann
    Chieffo, Nicole
    Thian Kheoh
    Haqq, Christopher M.
    Scher, Howard I.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (21): : 1995 - 2005
  • [5] Abiraterone prolongs survival in metastatic prostate cancer
    Oliver Sartor
    [J]. Nature Reviews Clinical Oncology, 2011, 8 : 515 - 516
  • [6] Re: Abiraterone in Metastatic Prostate Cancer Without Previous Chemotherapy
    Di Lorenzo, Giuseppe
    Buonerba, Carlo
    [J]. EUROPEAN UROLOGY, 2013, 63 (05) : 961 - 961
  • [7] Re: Cabazitaxel Versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer
    Mori, Keiichiro
    Egawa, Shin
    Shariat, Shahrokh F.
    [J]. EUROPEAN UROLOGY, 2020, 77 (06) : 758 - 759
  • [8] Re: Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer
    Taneja, Samir S.
    [J]. JOURNAL OF UROLOGY, 2020, 203 (04): : 662 - 663
  • [9] Re:Cabazitaxel Versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer
    Rubio-Briones, Jose
    [J]. EUROPEAN UROLOGY, 2020, 77 (04) : 560 - 561
  • [10] COMBINATION THERAPY Abiraterone prolongs survival in metastatic prostate cancer
    Sartor, Oliver
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (09) : 515 - 516
12345